Clinical Trials Logo

Clinical Trial Summary

A new wearable patch-type device, ATP-C120 (ATsens, Seongnam, Korea) is a novel, single-lead ECG monitoring device and can continuously monitor the ECG signal for upto 11 days. This study is designed to experiment its diagnostic capability of new-onset atrial fibrillation in high risk patients. Several studies reported that validated CHA2DS2-VASc score has high performance in predicting new-onset atrial fibrillation and there are over 10 percent of new-onset atrial fibrillation in patients whose calculated CHA2DS2-VASc scores are ≥ 2. Thus, through this study, the investigators sought to evaluate the validation of early detection of new-onset atrial fibrillation by ATP-C120.


Clinical Trial Description

The prevention of stroke associated with atrial fibrillation is a leading global health concern. This devastating event is largely preventable with anticoagulant therapy. Therefore, the early detection and accurate diagnosis of arrhythmia are crucial for prevention of adverse outcome. However, because atrial fibrillation is often intermittent and mostly asymptomatic, it is difficult to capture an excise event. Conventional electrocardiogram (ECG) monitoring devices including multi-lead portable ECG monitoring device, event-detection monitoring device, and implantable ECG monitoring device are useful for early detection of atrial fibrillation, but these devices have various drawbacks such as requirement of multiple out-patient visits and need of invasive implantation of devices. A new wearable patch-type device, ATP-C120 (ATsens, Seongnam, Korea) is a novel, single-lead ECG monitoring device and can continuously monitor the ECG signal for upto 11 days. It has recently demonstrated its diagnostic capability and safety compared to the conventional ECG monitoring systems . Yet, it has not widely used in real-world. So, this study is designed to experiment its diagnostic capability of new-onset atrial fibrillation in high risk patients. Several studies reported that validated CHA2DS2-VASc score has high performance in predicting new-onset atrial fibrillation and there are over 10 percent of new-onset atrial fibrillation in patients whose calculated CHA2DS2-VASc scores are ≥ 2. Thus, through this study, the investigators sought to evaluate the validation of early detection of new-onset atrial fibrillation by ATP-C120. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04857268
Study type Interventional
Source Seoul National University Bundang Hospital
Contact Ju-Seung Kwun, MD.
Phone +82-10-9279-5372
Email [email protected]
Status Recruiting
Phase N/A
Start date November 13, 2020
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03866148 - Obstructive Sleep Apnoea and Cardiac Arrhythmias N/A
Not yet recruiting NCT04528511 - BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Completed NCT04118270 - Shared Decision-Making: AFib 2gether Mobile App N/A
Recruiting NCT03345615 - Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation N/A
Recruiting NCT03221777 - Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Not yet recruiting NCT03991754 - Prevention of New Onset AF After TAVI (PAF-TAVI Trial) Phase 3
Completed NCT03118518 - STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation N/A
Completed NCT03552588 - High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
Not yet recruiting NCT04870424 - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Phase 3
Suspended NCT04037319 - Atrial Fibrillation After Surgery for Colorectal Cancer
Not yet recruiting NCT03382990 - Stent Placement and the Risk of New-onset AF in Patients With AMI N/A
Completed NCT03523676 - Use of Red Cell Distribution Width for Prediction of New-onset Atrial Fibrillation in Critically Ill Sepsis Patients
Recruiting NCT04224545 - COlchicine in Cardiac Surgery Phase 4
Completed NCT01247974 - Evaluation Of New Onset Postoperative Atrial Fibrillation N/A
Completed NCT01590979 - Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation N/A
Not yet recruiting NCT04830774 - Natural History of COVID-19-Related Atrial Fibrillation N/A